TENS of thousands of Brits are estimated to be unknowingly living with the silent heart condition that nearly killed ...

A recent multicenter study has found that late gadolinium enhancement (LGE) on cardiovascular magnetic resonance (CMR) ...

Midleton man Daniel Ryan has asked members of the public to look out for a navy blue maternity bag - as it contains a child's ...

Background: Symptoms are among the most important factors impacting quality of life (QOL) in hypertrophic cardiomyopathy (HCM) patients, and reflect a poor prognosis. Whether emotional stress can ...

Take hypertrophic cardiomyopathy, or HCM, a primarily genetic condition that results in a thickening of the walls of the heart—specifically its left ventricle, which is the chamber that pumps ...

Patient randomization is underway in SONATA-HCM clinical trial evaluating Lexicon’s novel dual SGLT1 and SGLT2 inhibitor in this underserved and ...

Edgewise Therapeutics (NASDAQ: EWTX) is up 50% in a single session and 450% from recent lows for a reason. Its novel, oral, ...

Shares of biopharma outfit Edgewise Therapeutics ( EWTX -4.14%) soared more than 50% today, reaching a three-year high ...

A bill aimed at preventing the rising number of sudden cardiac arrests among student-athletes would mandate that schools are ...

A new analysis from SEQUOIA-HCM showed that treatment with aficamten was associated with beneficial changes in five indices reflecting structural, electrophysiologic and biomarker changes in patients ...

Rep. Frank Pallone (D-Long Branch)’s Cardiomyopathy Health, Education, Awareness, Research, and Training in Schools (HEARTS) ...

Edgewise Therapeutics announced topline data from Phase 1 and Phase 2 trials of EDG-7500 for obstructive hypertrophic ...